Table 2.
Current laboratory values of patient I-1 and affected son (II-2).
Test (reference ranges) | Patient | Son | |||
---|---|---|---|---|---|
9/2010 | 4/2011 Fasting |
7/2011 Fasting |
4/2011 Fasting |
7/2011 Fasting |
|
Ca (8.5–10.5 mg/dL) | 10.1 | 10.0 | 10.5 | 9.8 | 9.5 |
Phosphorus (2.6–4.5 mg/dL) | 1.9 | 3.5 | 2.9 | 2.9 | 3.2 |
Magnesium (1.4–2.0 meq/L) | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 |
Vitamin D (> 32 ng/mL) | 34 | 22 | 39 | 21 | |
1,25 Vitamin D (18–78 pg/mL) | 10 | 14 | 43.5 | 39 | |
Albumin (3.3–5.0 g/dL) | 4.3 | 4.2 | 4.4 | 4.8 | |
Alkaline phosphatase (30–100 U/L) | 108 | 78 | 79 | 103 | |
Parathyroid hormone (10–60 pg/mL) |
30 | 30 | 21 | 42 | 47 |
FGF23 (< 180 RU/mL) | 785 | 414 | 70 | ||
Creatinine (0.60–1.50 mg/dL) | 1.14 | 1.0 | 0.99 | 0.8 | 0.82 |
Glucose (70–110 mg/dL) | 143 | ||||
Tubular reabsorption of phosphorus (> 80%, calculated based on creatinine) |
47.4% | 89.7% | 84.2%. | 89.0% | 89.8% |
T1-TSH (0.40–5.00 uU/mL) | 3.66 | 5.03 | 2.30 | ||
Hemoglobin (12.0–16.0 g/dL) | 12.7 | 13.0 | 13.9 | ||
Fe (30–160 µg/dL) | 118 | 80 | |||
TIBC (230–404 µg/dL) | 365 | 303 | |||
Ferritin (10–200 ng/mL) | 29 | 71 |